Lipopolysaccharide (LPS) and zymosan-resistant mutant isolated from a macrophage-like cell line, WEHI-3, with a defective response to LPS under serum-free conditions.

Ohki, K; Amano, F; Kohashi, O

Ohki, K; Amano, F; Kohashi, O.

Affiliation

Ohki K; Department of Microbiology, Saga Medical School, Saga, Japan. ohki@smsnet.saga-med.ac.jp

Immunol Cell Biol ; 79(5): 462-71, 2001 Oct.

Article in En | MEDLINE | ID: mdl-11564154

Subject(s)

Lipopolysaccharides/pharmacology; Macrophage Activation; Macrophages/immunology; Nitric Oxide/metabolism; Tumor Necrosis Factor-alpha/metabolism; Zymosan/pharmacology; Animals; Cell Line; Culture Media, Serum-Free; Flow Cytometry; Humans; Interferon-gamma/pharmacology; Lipid A/pharmacology; Macrophages/drug effects; Macrophages/metabolism; Mice; Signal Transduction/physiology; Tumor Necrosis Factor-alpha/genetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Zymosan / Lipopolysaccharides / Tumor Necrosis Factor-alpha / Macrophage Activation / Macrophages / Nitric Oxide Limits: Animals / Humans Language: En Journal: Immunol Cell Biol Journal subject: ALERGIA E IMUNOLOGIA Year: 2001 Document type: Article Affiliation country: Japan Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links